Jiangsu Hengrui reported CNY4.25B in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Cspc Pharmaceutical CNY 10.18B 65.36M Dec/2025
Kangmei Pharma CNY 5.38B 433.79M Mar/2026
Sh Fosun Pharma CNY 38.6B 2.02B Jun/2026
Sh Pharmaceutical CNY 140.42B 3.91B Jun/2026
Sino Biopharmaceutical CNY 24.85B 5.29B Jun/2025
Wuxi Apptec CNY 28.79B 9.75B Jun/2026
Zz Pientze Pharmaceu CNY 3.02B 742.54M Jun/2026